Mobile

A prospective non-randomized study of 131I-L19SIP Radioimmunotherapy (RIT) in combination with Whole Brain Radiation Therapy (WBRT) in patients with multiple brain metastases from solid tumors

Mise à jour : Il y a 4 ans
Référence : EUCTR2009-013002-13

Femme et Homme

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

To evaluate the safety of the administration of radioimmunotherapy with 131I-L19SIP combined with whole brain radiation treatment (the standard treatment)and to determine the selective uptake of the study drug (131I-L19SIP) in the brain lesions.

Critère d'inclusion

  • Patients with multiple brain metastases (>1) of solid tumors, who have not received prior external beam irradiation to the brain

Liens